Eva Fortea Verdejo
Stock Analyst at Wells Fargo
(4.49)
# 298
Out of 5,130 analysts
22
Total ratings
62.5%
Success rate
39.43%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Eva Fortea Verdejo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLAY Relay Therapeutics | Upgrades: Overweight | $6 → $13 | $7.99 | +62.70% | 2 | Dec 12, 2025 | |
| ZYME Zymeworks | Upgrades: Overweight | $25 → $33 | $23.17 | +42.43% | 4 | Dec 12, 2025 | |
| BCAX Bicara Therapeutics | Maintains: Equal-Weight | $8 → $11 | $17.95 | -38.72% | 3 | Nov 11, 2025 | |
| IMCR Immunocore Holdings | Initiates: Overweight | $60 | $33.00 | +81.82% | 1 | Oct 31, 2025 | |
| RCUS Arcus Biosciences | Maintains: Overweight | $25 → $29 | $21.01 | +38.03% | 4 | Oct 20, 2025 | |
| KNSA Kiniksa Pharmaceuticals International, | Maintains: Overweight | $42 → $45 | $42.67 | +5.46% | 3 | Sep 25, 2025 | |
| RVMD Revolution Medicines | Maintains: Overweight | $67 → $70 | $118.64 | -41.00% | 1 | Sep 11, 2025 | |
| XNCR Xencor | Maintains: Overweight | $33 → $27 | $13.89 | +94.38% | 3 | Aug 7, 2025 | |
| IDYA IDEAYA Biosciences | Initiates: Overweight | $44 | $37.36 | +17.77% | 1 | Jun 26, 2025 |
Relay Therapeutics
Dec 12, 2025
Upgrades: Overweight
Price Target: $6 → $13
Current: $7.99
Upside: +62.70%
Zymeworks
Dec 12, 2025
Upgrades: Overweight
Price Target: $25 → $33
Current: $23.17
Upside: +42.43%
Bicara Therapeutics
Nov 11, 2025
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $17.95
Upside: -38.72%
Immunocore Holdings
Oct 31, 2025
Initiates: Overweight
Price Target: $60
Current: $33.00
Upside: +81.82%
Arcus Biosciences
Oct 20, 2025
Maintains: Overweight
Price Target: $25 → $29
Current: $21.01
Upside: +38.03%
Kiniksa Pharmaceuticals International,
Sep 25, 2025
Maintains: Overweight
Price Target: $42 → $45
Current: $42.67
Upside: +5.46%
Revolution Medicines
Sep 11, 2025
Maintains: Overweight
Price Target: $67 → $70
Current: $118.64
Upside: -41.00%
Xencor
Aug 7, 2025
Maintains: Overweight
Price Target: $33 → $27
Current: $13.89
Upside: +94.38%
IDEAYA Biosciences
Jun 26, 2025
Initiates: Overweight
Price Target: $44
Current: $37.36
Upside: +17.77%